Patents by Inventor Kyle P. McLaughlin

Kyle P. McLaughlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANUCLEATED CELLS AND USES THEREOF
    Publication number: 20220143095
    Abstract: Disclosed herein are non-naturally existing novel platelet variants or platelet like cells (PLCs), extracellular vesicles (EVs), and derivatives thereof. Composition comprising the same and methods for treatment or prevention of diseases or disorders therewith is also disclosed.
    Type: Application
    Filed: January 21, 2022
    Publication date: May 12, 2022
    Inventors: Sunita R. Hett, Karen Weisinger, Yang Peng, Kyle P. McLaughlin, Christian G. Peters, Andrew R. Zukauskas, Brenden W. Smith, Silvia Giannini, Marcus Lehmann
  • ANUCLEATED CELLS FOR THE TREATMENT OF DISEASES
    Publication number: 20210299181
    Abstract: The present disclosure takes advantage of non-naturally existing, novel, anucleated platelets or platelet-like cells or platelet variants (collectively referred to as PLCs) or derivatives thereof (i.e., genetically engineered), which share at least one common receptor, ligand or an antigen with endogenous cells that are targets for autoantibodies and effectuate their clearance. The present disclosure also takes advantage of viral adhesion or entry receptors or genetically engineered PLCs or derivatives thereof, which are engineered to express viral adhesion or entry receptors, that specifically binds to viral proteins on viruses or viral particles and effectuate their clearance.
    Type: Application
    Filed: March 26, 2021
    Publication date: September 30, 2021
    Inventors: Sunita R. Hett, Karen Weisinger, Yang Peng, Kyle P. McLaughlin, Christian G. Peters, Andrew R. Zukauskas, Brenden W. Smith, Silvia Giannini, Po-Shun Lee
  • NOVEL ANUCLEATED CELLS AND USES THEREOF
    Publication number: 20210299180
    Abstract: Disclosed herein are non-naturally existing novel platelet variants or platelet like cells (PLCs), extracellular vesicles (EVs), and derivatives thereof. Composition comprising the same and methods for treatment or prevention of diseases or disorders therewith is also disclosed.
    Type: Application
    Filed: March 26, 2021
    Publication date: September 30, 2021
    Inventors: Sunita R. Hett, Karen Weisinger, Yang Peng, Kyle P. McLaughlin, Christian G. Peters, Andrew R. Zukauskas, Brenden W. Smith, Silvia Giannini, Marcus Lehmann